Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Autor: de Heer, E. C.1 (AUTHOR), Zois, C. E.2,3,4 (AUTHOR) christos.zois@oncology.ox.ac.uk, Bridges, E.2 (AUTHOR), van der Vegt, B.5 (AUTHOR), Sheldon, H.2 (AUTHOR), Veldman, W. A.1 (AUTHOR), Zwager, M. C.5 (AUTHOR), van der Sluis, T.5 (AUTHOR), Haider, S.6 (AUTHOR), Morita, T.7 (AUTHOR), Baba, O.7 (AUTHOR), Schröder, C. P.1,8 (AUTHOR), de Jong, S.1 (AUTHOR), Harris, A. L.2 (AUTHOR), Jalving, M.1 (AUTHOR) m.jalving@umcg.nl
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 8/28/2023, Vol. 42 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje